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Abstract
Objectives: To investigate the effect of chronic lung inflammation on the incidence and severity of collagen-
induced arthritis in mice.
Methods: Chronic lung inflammation in the form of silicosis was induced via intranasal application of silica
particles. Immunization with collagen Type II commenced one week later and mice were sacrificed six weeks after
booster immunization. Thereafter, silicosis was confirmed via flow cytometry and arthritis was evaluated performing
knee and paw histology.
Results: Pronounced lung inflammation in the silica-treated compared to PBS-treated control mice was
demonstrated by significantly elevated broncho-alveolar lavage (BAL) cell count, attributable to increased numbers
of macrophages and granulocytes. Inflammation in the lungs was not associated with elevated PAD2 and PAD4
expression, yet silica treated animals had significantly higher aCCP serum titers. However, lung inflammation did not
lead to an increase in the incidence of arthritis, nor did it exacerbate the macroscopic or histologic joint scores.
Conclusions: Chronic lung inflammation resulting from silicosis does not aggravate collagen-induced arthritis in
mice.
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Background
Rheumatoid arthritis (RA) is a systemic autoimmune
disease which manifests predominantly as a chronic
polyarthritis. The autoantibodies against citrullinated an-
tigens (ACPA) have become indispensable for RA diag-
nosis and define a distinct subset of RA for which a
variety of genetic and environmental risk factors have
been described. While the strongest genetic risk is con-
ferred by genes encoding the major histocompatibility
complex (HLA), environmental risk factors include
smoking, exposure to silica particles and air pollution as
well as periodontitis and the recently discussed gastro-
intestinal microbiota [1, 2].
Among these, smoking is the most extensively studied
risk factor for RA. It predisposes for ACPA-positive RA
in subjects carrying the shared HLA epitope [3]. Not
only the expression of the citrullinating enzyme peptidy-
larginine deiminase (PAD) 2 but also citrullinated
proteins are elevated in the lungs of smokers compared
to non-smokers [4]. These findings suggested that smok-
ing causes an increase in citrullination which eventually
leads to the breach in tolerance. However, a recent re-
port demonstrated that it is not the cigarette smoke per
se that increases citrullination in the lungs. In fact, it ap-
pears that it is inflammation associated with smoking
that is responsible for elevated levels of citrullinated lung
proteins as the latter were also demonstrated for patients
with chronic obstructive pulmonary disease (COPD) [5].
We therefore set out to investigate the effect of silicosis -
a model for chronic lung inflammation - on collagen-
induced arthritis, a murine model for RA.
Methods
Mice
Female DBA/1J (Charles River, Wilmington, MA, USA)
and male B10.q (Jackson) mice were crossed. Parental
and F1 mice were maintained in a specific pathogen free
unit on a 12 h light/12 h dark cycle with 30 min twilight
period. The ambient temperature was 21 ± 2°C, the
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humidity was 60 ± 10% and the room air change is 20-
fold. Mice were housed using a stocking density of 3–5
mice per cage. Mice were given water and ssniff R/M-H
diet (ssniff Spezialdiäten GmbH, Soest, Germany) ad
libitum.
Silicosis
A solution of 40 mg silica particles [particle size range:
0.5–10 μm, 80% are 1–5 μm] (Sigma Aldrich, St. Louis,
MO, USA) per ml PBS was prepared and sonicated for
10 min prior to use. Male F1 mice aged 6–12 weeks
were anesthetized by i.p. injection of 75 mg/kg ketamine
(bela-pharm GmbH & Co. KG, Vechta, Germany) and
6 mg/kg xylazine (Bayer AG, Leverkusen, Germany).
Two droplets of 15μl of silica solution each were sub-
sequently applied onto the noses of the anesthetized
animals. Controls were given the same amount of
PBS alone. The suspension was inhaled involuntarily
and mice developed pulmonary inflammation as de-
scribed previously [6].
Collagen-induced arthritis
Collagen-induced arthritis was induced one week after
intranasal treatment with silica particles or PBS. Bovine
collagen type II (MD Bioscience, St. Paul, MN, USA)
was dissolved at a concentration of 2 mg/ml in sterile
0.1M acetic acid by stiring overnight at 4°C. Complete
Freunds’ adjuvant (CFA) was prepared by thoroughly
mixing 25 ml incomplete Freunds’ adjuvant (IFA) (Difco,
Detroit, MI, USA) with 100 mg M. tuberculosis H37
RA (Difco, Detroit, MI, USA). For the primary
immunization 400 μl CFA was mixed with 400 μl col-
lagen solution and 100 μl/mouse were injected intra-
dermally at the tail base. Booster immunization was
performed 3 weeks after primary immunization using
IFA instead of CFA. Mice were scored weekly, follow-
ing an extended scoring protocol whereby each paw
was scored for macroscopic signs of arthritis. Each af-
fected distal joint of the toe/knuckle scored one point
and affected midpaws/ankles scored five points. Thus,
each paw can reach a maximum score of 15 and each
mouse a maximum score of 60.
Evaluation of silicosis
Six weeks after booster immunization, animals were
anesthetized and broncho-alveolar lavage cells were iso-
lated by flushing the lungs 3 times with 800 μl PBS pH
7.4 containing 0.1 mM EDTA. Collected cells were
counted in a hemocytometer and subsequently centri-
fuged at 300×g for 10 min. Cell pellets were then resus-
pended in 100 μl ice-cold PBS pH 7.4, 0.5% bovine
serum albumin, 0.1% sodium azide and therein stained
for CD11c: FITC (clone HL3, BD, Franklin Lakes, NJ,
USA), CD45:PE (clone 30-F11, Biolegend, San Diego,
CA, USA), GR-1: PECy7 (clone RB6-8C5, Biolegend, San
Diego, CA, USA) and IAq: Alexa647 (clone KH116,
Biolegend, San Diego, CA, USA). Cells were analyzed in
a BD FACS Calibur (BD, Franklin Lakes, NJ, USA).
Histology
Paws and knees were excised and fixed in 4% parafor-
maldehyde for 5 days. Paraformaldehyde was removed
under floating tap water for 30 min and tissues were
transferred into USEDECALC (Medite GmbH, Burgdorf,
Germany) for decalcification for 5 days (knees) or 2
weeks (paws). Tissue samples were paraffin-embedded
and 5 μm thin-sections were made. Sections were depar-
affinized and rehydrated prior to staining with haema-
toxylin/eosin. Stained sections were scored on an
Axioplan 2 microscope (Carl Zeiss AG, Oberkochen,
Germany) using a previously published scoring system
[7]. In brief, knee joints we scored for inflammation
(evaluating the degree of infiltration yielding a score be-
tween 0 and 3), cartilage destruction (normal via empty
lacunae up to complete loss of articular cartilage, again
yielding a score between 0 and 3) and bone loss (yielding
scores between 0 and 5). The total of all three parame-
ters will result in a maximum score of 11. The paws
were graded differently and for the parameters pannus
severity, cellular infiltration, cartilage destruction and
bone loss, each yielding a score between 0 and 4. Each
paw could thus reach a maximum score of 16 and all
four paws per mouse were averaged.
Serum antibodies
ACPA IgG levels were measured by combining CCP-
(Euroimmun, Lübeck, Germany; CCP2) and MCV-
(Orgentec, Mainz, Germany) coated ELISA plates with
an anti-mouse IgG antibody coupled to horse radish per-
oxidase (STAR13B; Bio-Rad Laboratories, Hercules, CA,
USA). The sera were applied at a dilution of 1:50 for 1h
at RT. Thereafter, the plates were incubated with the de-
tection antibody at a dilution of 1:1000 for 1h. Finally,
color reaction was performed using TMB substrate
(Biolegend, Fell, Germany) and the optical densities were
determined by an automated plate reader (Millenia
Kinetic Analyser, DPC, USA). Antibody serum levels
against collagen type II were analyzed by coating Nunc
MediSorp ELISA plates (Thermo Fisher Scientific,
Waltham, MA, USA) with bovine collagen type II (MD
Bioscience, St. Paul, MN, USA) at 20μg/ml in carbonate/
bicarbonate buffer overnight at 4°C. Sera were applied at
a dilution of 1:12,000 for 1.5h at RT and bound anti-
bodies were detected as described for ACPA detection.
Statistics
For normal distributed data means and SEM are shown.
Otherwise medians and quartiles are used. Means were
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compared by Student’s t-test and medians were com-
pared by Mann Whitney U-test. P-values for the time
course of CIA were calculated either by Fisher Test
(incidence) or by Mann–Whitney U-Test (macroscopic
score) for each time point separately. Statistics were per-
formed using R (v3.2.2).
Results
Intranasal application of silica particles in mice led to a
longstanding inflammation. The broncho-alveolar lavage
(BAL) of silica treated and control mice was analyzed
ten weeks after the induction of silicosis and indeed,
there was a significant increase in the total numbers of
BAL cells (p < 0.001), in particular macrophages (p = 0.03)
and granulocytes (p < 0.001) after silica-treatment (Fig. 1a).
Despite the longstanding inflammation, we could not
detect a difference in the expression of PAD2 and PAD4
between silica treated and PBS treated mice (Additional
file 1: Figure S1).
In contrast, silicosis had no impact on the incidence
and severity of collagen induced arthritis. Primary
immunization with collagen commenced one week after
silica treatment and mice were then followed up for the
rest of the observation period. At the final time point,
six weeks after booster immunization, there were no dif-
ferences between the silicosis and the control groups
with respect to arthritis incidence and severity, the latter
being scored macroscopically as well as histologically for
knees and paws (Fig. 1b, c, histology is exemplified in
Fig. 1d). Likewise, there was no correlation between the
numbers of total BAL cells, BAL macrophages or BAL
granulocytes and the macroscopic arthritis score
(Additional file 1: Figure S1, data not shown) nor did
we find significant differences in anti-collagen type II
and anti-MCV IgG serum level comparing silica
treated and PBS treated mice. However, we did find
significant difference between silica treated and PBS
treated mice for anti-CCP IgG serum level (p = 0.02;
Fig. 1 Silicosis does not aggravate collagen-induced arthritis. a BAL cells from mice six weeks after booster immunization with collagen type II
were isolated and phenotyped by flow cytometry for macrophages (CD45+IAq+GR-1−CD11c+) and granulocytes (CD45+IAq−GR-1+CD11c−). Boxes
show medians and quartiles, p-values were calculated by Mann–Whitney U-test. n = 14. b Neither the arthritis incidence (left panel) nor the
macroscopic arthritis score (right panel) differ between silica-treated and control mice. p-values were calculated by Fisher Test (incidence) and
Mann–Whitney U-Test (macroscopic score) for each time point. c Histological scores for knee joints and paws do not differ between silica-treated
and control mice. Boxes show median and quartiles, each dot represents one mouse. P-values were calculated by Mann–Whitney U-Test. d Examples
for the H&E staining of thin-sections from femorotibial joints in control mice without immunization with collagen type II (upper left panel), silica-
treated mice immunized with collagen type II (upper right panel) and PBS-treated mice immunized with collagen type II (lower panels) showing a high
(lower right panel) or a low (lower left panel) histological score are shown. Asterisks indicate inflammatory infiltrates. Arrowheads point at sites of
cartilage or bone destruction
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Additional file 1: Figure S1) and we also found a sig-
nificant correlation between anti-collagen type II IgG
and the macroscopic arthritis score (R = 0.65, p < 0.001).
We therefore conclude that silica induced chronic lung in-
flammation in the mouse does not aggravate collagen in-
duced arthritis.
Discussion
Over the last years, studies accumulated on the genetic
and environmental risk factors for RA and on factors
driving the disease. Nevertheless, it is still unclear where
and by which mechanisms the first break of tolerance
occurs [8]. The mucosal surfaces and mucosa associated
lymphoid tissues (MALT) are likely to play critical roles
as the most prominent risk factors for RA - smoking,
periodontitis, gastrointestinal microbiota and silicosis -
affect mucosal immunity. We therefore made use of a
murine silicosis model to induce a chronic lung inflam-
mation. Despite this chronic inflammatory reaction in
the lungs we did not see an exacerbation of the CIA.
However, this may be due to the timing between silicosis
induction and CIA induction. We decided for a one
week interval between silicosis induction and primary
immunization with collagen in order to ensure that a full
blown inflammation has been established. At five weeks
after silicosis treatment – which corresponds to one
week after the booster immunization – arthritis starts to
be macroscopically visible and silicosis is in its chronic
phase. Indeed, it has previously been shown that inflam-
matory markers increased already one day after the
treatment with silica particles, peaking at 5 days and
lasting up to 60 days with fibrosis evident at 15 days
after silicosis induction [9–11]. Thus, our protocol
covers all phases of silicosis.
It is unknown which factors influence the interaction
between silicosis and arthritis. However, it has been de-
scribed that silica treatment induces apoptosis in macro-
phages, which in turn increase citrullination due to
elevated intracellular calcium concentrations [4, 12]. An
increase in citrullination may aggravate arthritis as de-
scribed for the administration of citrullinated collagen
[13]. On the other side, it is known that silica treatment
can recruit CD4 + Foxp3+ regulatory T cells to the lungs
which may counteract immune activation [14]. Although
we did not find increased PAD2/4 expression levels in
the lungs after silica treatment an increase in intracellu-
lar calcium levels would still lead to citrullination by
PAD enzymes which is in line with slightly elevated anti-
CCP levels in our silica treated mice. However, these dif-
ferences did not influence the severity of arthritis.
For the induction of CIA male sex and the major
histocompatibility allel Aq are crucial factors, which are
all met in our model [15–17]. Likewise, complex interac-
tions between genetics and the immune system hold true
for the development of silicosis [18, 19]. Thus, by focus-
ing on a mouse strain that is highly susceptible for CIA
we may have missed factors that are essential for an
interaction between silicosis and arthritis. Furthermore,
we cannot rule out that a specific activation of pattern-
recognition receptors contributes to CIA development
yet is lacking from silicosis under specific pathogen free
conditions.
Conclusions
In summary our results suggest that factors other than
chronic inflammation in mucosal environments are ne-
cessary to compromise immune tolerance in the murine
model of CIA. Such factors may well include genetic
polymorphisms as previously shown for the gene-
environment interaction between the HLA shared epi-
tope and smoking in human ACPA-positive RA [3].
Additional files
Additional file 1: Figure 2. Additional information. (A) Before we did
the combination of silicosis and CIA we performed a time course
experiment with silicosis induction only. Eight weeks after silica or PBS
treatment we sacrificed the mice and analyzed the mRNA expression of
PAD2 and PAD4 in lung tissue. We did not find significant differences
between the treatment and control groups nor during the time course
of silicosis. (B) H&E stainings of the lung exemplify healthy tissue (upper
panel) in PBS treated mice and lung tissue with ongoing inflammation
(asterisk, lower panel) in silica treated mice. (C) Serum IgG antibody levels
against mutated citrullinated vimentin (MCV), cyclic-citrullinated peptides
(CCP) and collagen type II (Col2) show significantly higher levels of anti-
CCP IgG among silica treated mice as compared to PBS treated mice
(same animals as in Fig. 1). There is no difference between both groups
for anti-MCV and anti-Col2 IgG. (D) No correlation exists between the
number of BAL granulocytes and the macroscopic arthritis score. Spearman
correlation (R = 0.22, p = 0.3). However, anti-Col2 IgG levels are significantly
correlated with the macroscopic arthritis score. Spearman correlation
(R = 0.65, p < 0.001) (same animals as in Fig. 1). (TIFF 2253 kb)
Additional file 2: Original data. (CSV 5 kb)
Acknowledgements
We thank Ilona Klamfuß and Karin Gerber for animal care.
Funding
The source of funding is the Fritz Thyssen Stiftung (http://www.fritz-thyssen-
stiftung.de, grant number: 10.12.2.146) and an intramural grant (FORUN
889018–2013). The funding agencies had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Availability of data and material
All data generated and analysed during this study are included in this
published article and its supplementary information file [Additional file 2:
Primary data].
Authors’ contributions
RE and BMH were involved in the experimental design. RE performed all
experiments. RE and BMH wrote the manuscript and read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Engelmann and Müller-Hilke Journal of Negative Results in BioMedicine  (2017) 16:5 Page 4 of 5
Ethics approval
All animal experiments were performed in accordance with the guidelines of
the local animal use and care committee. This study was approved by the
“Landesamt für Landwirtschaft, Lebensmittelsicherheit und Fischerei
Mecklenburg-Vorpommern” (approval no. 7221.3-1.2-044/12). Animal housing
was done by professional animal keepers. Animals were anesthetized using
ketamine/xylazine prior to silika treatment and sacrified by cervical dislocation
at the end of the study. All efforts were made to minimize suffering.
Received: 29 November 2016 Accepted: 15 February 2017
References
1. Taneja V. Arthritis susceptibility and the gut microbiome. FEBS Lett.
2014;588:4244–9.
2. Essouma M, Noubiap JJN. Is air pollution a risk factor for rheumatoid
arthritis? J Inflamm (Lond). 2015;12. doi:10.1186/s12950-015-0092-1.
3. Lundström E, Källberg H, Alfredsson L, Klareskog L, Padyukov L. Gene-
environment interaction between the DRB1 shared epitope and smoking in
the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis:
All alleles are important. Arthritis Rheum. 2009;60:1597–603.
4. Makrygiannakis D, Hermansson M, Ulfgren A-K, Nicholas AP, Zendman AJW,
Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases
peptidylarginine deiminase 2 enzyme expression in human lungs and
increases citrullination in BAL cells. Ann Rheum Dis. 2008;67:1488–92.
5. Lugli EB, Correia RE, Fischer R, Lundberg K, Bracke KR, Montgomery AB, Kessler
BM, Brusselle GG, Venables PJ. Expression of citrulline and homocitrulline
residues in the lungs of non-smokers and smokers: implications for
autoimmunity in rheumatoid arthritis. Arthritis Res Ther. 2015;17:9.
6. Lacher SE, Johnson C, Jessop F, Holian A, Migliaccio CT. Murine pulmonary
inflammation model: a comparative study of anesthesia and instillation
methods. Inhal Toxicol. 2010;22:77–83.
7. Seeuws S, Jacques P, Van Praet J, Drennan M, Coudenys J, Decruy T,
Deschepper E, Lepescheux L, Pujuguet P, Oste L, Vandeghinste N, Brys R,
Verbruggen G, Elewaut D. A multiparameter approach to monitor disease
activity in collagen-induced arthritis. Arthritis Res Ther. 2010;12:R160.
8. Valesini G, Gerardi MC, Iannuccelli C, Pacucci VA, Pendolino M, Shoenfeld Y.
Citrullination and autoimmunity. Autoimmun Rev. 2015;14:490–7.
9. Rabolli V, Lo Re S, Uwambayinema F, Yakoub Y, Lison D, Huaux F. Lung
fibrosis induced by crystalline silica particles is uncoupled from lung
inflammation in NMRI mice. Toxicol Lett. 2011;203:127–34.
10. Lee EH, Lee E, Kim HJ, Jang AS, Koh ES, Uh S-T, Kim YH, Park S-W, Park C-S.
Overexpression of apolipoprotein A1 in the lung abrogates fibrosis in
experimental silicosis. PLoS One. 2013;8:e55827.
11. Song L, Weng D, Dai W, Tang W, Chen S, Li C, Chen Y, Liu F, Chen J. Th17
can regulate silica-induced lung inflammation through an IL-1β-dependent
mechanism. J Cell Mol Med. 2014;18:1773–84.
12. Joshi GN, Knecht DA. Silica phagocytosis causes apoptosis and necrosis by
different temporal and molecular pathways in alveolar macrophages.
Apoptosis. 2013;18:271–85.
13. Thiele GM, Duryee MJ, Dusad A, Hunter CD, Lacy JP, Anderson DR, et al.
Citrullinated mouse collagen administered to DBA/1J mice in the absence
of adjuvant initiates arthritis. Int Immunopharmacol. 2012;13:424–31.
14. Lo Re S, Lecocq M, Uwambayinema F, Yakoub Y, Delos M, Demoulin J-B, et
al. Platelet-derived growth factor–producing CD4+ Foxp3+ regulatory T
lymphocytes promote lung fibrosis. Am J Respir Crit Care Med.
2011;184:1270–81.
15. Holmdahl R, Jansson L, Andersson M. Female sex hormones suppress
development of collagen-induced arthritis in mice. Arthritis Rheum.
1986;29:1501–9.
16. Brunsberg U, Gustafsson K, Jansson L, Michaëlsson E, Ahrlund-Richter L,
Pettersson S, Mattsson R, Holmdahl R. Expression of a transgenic class II Ab
gene confers susceptibility to collagen-induced arthritis. Eur J Immunol.
1994;24:1698–702.
17. Holmdahl R, Bockermann R, Bäcklund J, Yamada H. The molecular
pathogenesis of collagen-induced arthritis in mice—a model for
rheumatoid arthritis. Ageing Res Rev. 2002;1:135–47.
18. Davis GS, Leslie KO, Hemenway DR. Silicosis in mice: effects of dose, time,
and genetic strain. J Environ Pathol Toxicol Oncol. 1998;17:81–97.
19. Ohtsuka Y, Wang X-T, Saito J, Ishida T, Munakata M. Genetic linkage analysis
of pulmonary fibrotic response to silica in mice. Eur Respir J. 2006;28:1013–19.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Engelmann and Müller-Hilke Journal of Negative Results in BioMedicine  (2017) 16:5 Page 5 of 5
